Mountain Group Capital
VC Fund
Nashville, United States
Mountain Group Capital is a VC fund in Nashville focused on Biotechnology and Health Care. Mountain Group Capital invests based on 4 core principles: Invest in the team first, idea second Invest based on business fundamentals, not financial engineering Invest as if you will own the business forever If possible, own the business forever
- Total investments:
- 69
- Last investment:
- Lead investor:
- 25%
- Fund size:
- $22M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Mountain Group Capital invests in
Stages Mountain Group Capital invests in
Countries Mountain Group Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Biotechnology 21 (30%)
- Health Care 19 (28%)
- Medical 10 (14%)
- Medical Device 6 (9%)
- Health Diagnostics 6 (9%)
Stage
- Series A 14 (20%)
- Series B 13 (19%)
- Seed 9 (13%)
- Funding Round 9 (13%)
- Series C 6 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Byron W. Smith
Managing Director
|
Managing Director | Total investments: 6 | Find email | |
Joe Cook III
Managing Director
|
Managing Director | Total investments: 5 | Find email | |
Rob Readnour
Managing Director
|
Managing Director | Total investments: 7 | Find email | |
Terry Vance
Advisor
|
Advisor | Total investments: 0 | Find email | |
Tyler Whitmore
Vice President
|
Vice President | Total investments: 0 | Find email | |
| See all 12 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Angel Eye Health
|
AngelEye provides a complete HIPAA-compliant tele-engagement platform to integrate parents simply and seamlessly into the child's care team. We deliver proven, positive impact on the family experience, care delivery workflows, and patient outcomes supporting a successful transition home. From bedside cameras, patient communication, feedingmanagement, and focused education, our solutions support the specialized needs of the NICU. | $9M / Series C / Dec 09, 2025 | |
MiNDERA Corporation
|
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases. The company is currently focused on a technology solution to extract skin biomarkers in a non-invasive manner. It was founded in 2013 and is based in San Francisco, United States. | $25.4M / Convertible Note / Jul 31, 2024 | |
PinkDx
|
PinkDx is a biotechnology company. | $40M / Series A / Apr 25, 2024 | |
Circular Genomics
|
Circular Genomics develops circular RNA (circRNA)-based diagnostic and biomarker tools for neurological and psychiatric disorders. The company uses brain-derived circRNAs, a class of stable non-coding RNA molecules enriched in the brain, to build blood-based assays that reflect disease biology in real time. Its first product, MindLight™, predictswhether a patient with major depressive disorder will respond to SSRI antidepressants. Circular Genomics is also creating additional assays designed for early detection and risk prediction of neurodegenerative diseases such as Alzheimer’s disease. The company applies its circRNA platform to help clinicians make more informed treatment decisions using molecular indicators of brain health. | $8.3M / Series A / Jan 23, 2024 | |
Airvet
|
AirVet is a telehealth platform designed to offer continuity of care between pet parents and veterinarians. It aims to support and strengthen existing relationships between veterinarians and clients. Veterinarians can engage with clients or with pet parents through video or real-time chat to drive clinic revenue and create a continuity of care notachievable before, while becoming a part of an innovative veterinary community.The company was founded on 2018 and is headquartered in Los Angeles, California. | $18.2M / Series B / May 24, 2023 | |
Vytelle
|
Vytelle is a company with a deeper purpose and revolutionary technology that helps to advance bovine, deer and buffalo genetics faster by redefining reproduction. | $20M / Series B / Apr 04, 2023 | |
Silicon Ranch
|
Silicon Ranch develops, owns, and operates solar energy plants, offering customized renewable energy, carbon, and battery storage solutions. The company maintains long-term ownership of its projects, ensuring ongoing community partnerships. Through its Regenerative Energy® program, Silicon Ranch integrates regenerative land management practices,such as agrivoltaics, to enhance soil health and biodiversity. The company has a portfolio of over 3.6 gigawatts of solar and battery storage systems in operation. | $375M / Private Equity / Jan 05, 2023 | |
|
Angel Eye Health
|
AngelEye provides a complete HIPAA-compliant tele-engagement platform to integrate parents simply and seamlessly into the child's care team. We deliver proven, positive impact on the family experience, care delivery workflows, and patient outcomes supporting a successful transition home. From bedside cameras, patient communication, feedingmanagement, and focused education, our solutions support the specialized needs of the NICU. | $11.2M / Series B / Nov 10, 2022 | |
Verility
|
Verility is developing fertility products that enable us to address the critical demand for the projected need of more meat protein, resulting in improved food sustainability, by helping livestock producers and breeders accelerate reproductive performance through accurate, simple, and cost-effective analysis of animal semen samples at thepoint-of-care as well as ovulation prediction. | $4M / Series A / Jul 27, 2022 | |
TARGAN
|
Applied LifeSciences & Systems is a bio-systems company focused on improving animal health and productivity in the poultry, livestock, and aquaculture industries. ALS-S is developing a solution that revolutionizes current vaccination methods. Our technology will detect, target, and deliver vaccines to each and every chick, ensuring effectivevaccination. This one-of-a-kind accuracy and consistency in the vaccination process boosts the natural immune response to diseases, improves overall flock health, and provides for a cleaner, healthier chick. | $35M / Series C / May 25, 2022 | |
| See all 69 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Mountain Group Capital invest in?
Mountain Group Capital invests primarily in Biotechnology, Health Care and Medical startups, most often at Series A and Series B stage. Most of the 69 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mountain Group Capital?
Public channels for Mountain Group Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Mountain Group Capital?
The team at Mountain Group Capital includes Byron W. Smith (Managing Director), Joe Cook III (Managing Director) and Rob Readnour (Managing Director), among 12 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
